BNGO · Forms 3, 4, 5
Insider trades at Bionano Genomics, Inc.
1 insider bought $10K of Bionano Genomics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Bionano Genomics, Inc. (BNGO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Albert Luderer | Interim Chief Executive | Buy | 4,000 | $1.21 | $5K | Form 4 | |
| Albert Luderer | Interim Chief Executive | Buy | 4,000 | $1.22 | $5K | Form 4 | |
| Mark Adamchak | Principal Accounting Officer | Options or other derivatives | Form 4 | ||||
| Jonathan V. Dixon | General Counsel | Options or other derivatives | Form 4 | ||||
| Mark Oldakowski | Chief Operating Officer | Options or other derivatives | Form 4 | ||||
| Alex Reid Hastie | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Mark Oldakowski | Chief Operating Officer | Became an insider (Form 3) | Form 3 | ||||
| Mark Adamchak | Principal Accounting Officer | Became an insider (Form 3) | Form 3 | ||||
| Alex Reid Hastie | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Jonathan V. Dixon | General Counsel | Became an insider (Form 3) | Form 3 | ||||
| Alex Reid Hastie | Chief Scientific Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.